Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Impact · against what's priced in

Abivax's successful $800M public offering provides significant capital for its clinical-stage pipeline, though it introduces immediate shareholder dilution. The oversubscribed nature of the deal suggests strong institutional confidence in the company's valuation and long-term prospects.

ABVX+0.20: No priced-in read yet

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

What matters in this story

Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

What matters in this story

Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least

How each ticker is affected

Connected tickers

Track these names every morning.

DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line

Recce Pharmaceuticals signs Arrotex deal for RECCE 327 in Australia and New Zealand

Molina (MOH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

What matters in this story

Next reads from the same story arc

Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

What matters in this story

Next reads from the same story arc

Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least

How each ticker is affected

Connected tickers

Track these names every morning.

DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line

Recce Pharmaceuticals signs Arrotex deal for RECCE 327 in Australia and New Zealand

Molina (MOH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG